Search results
Results From The WOW.Com Content Network
Image source: Getty Images. 1. Coronavirus product growth shouldn't be a point of reference. Pfizer's revenue soared to a record level earlier in the pandemic, thanks to the company's market ...
There's no denying that the recent election results do appear to be weighing on investors, as Pfizer's stock has hit a new low since then. Today, the stock is trading at a heavily discounted ...
Wake up with Breakfast news in your inbox every market ... a dividend that yields 6.3% at today's share price. ... fetch a solid valuation on the stock market, but nope. Pfizer trades at just over ...
Recently, shares of Pfizer (NYSE:PFE) dropped 20% in a straight line following the company's latest earnings report. As a result, PFE stock has reached extreme oversold readings that -- in ...
Price Action: PFE stock is down 1.47% at $29.75 at last check Thursday. Read Next: Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Pfizer (PFE) closed at $51.40 in the latest trading session, marking a -0.62% move from the prior day.
Pfizer believes just 35% of its 2030 oncology revenue will come from today's products, meaning the pipeline should do a lot of heavy lifting as new products enter the market. In the meantime ...
Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is $1.55. Pfizer Just Reassured Investors, but Is the Stock a Buy? Skip to ...